2 ms·
The platform isn't the problem, it's the economic system for drug research. Science and free (copyleft) software are a gift economy, and they have outpaced prop
by EGreg 10y ago
The platform isn't the problem, it's the economic system for drug research. Science and free (copyleft) software are a gift economy, and they have outpaced proprietary software. We recognize that patents are bad in software, open source does better than the profit motive. What's more, it can serve the long tail way better!! While Windows runs on some devices, there are toasters that run Linux. Someone in the world could be Working to add knowledge that can lead to cures for Malaria and the Zika virus, unencumbered by patents. But we'd need prizes.
What would it take for this to become a drug? Well, studies and FDA approval, for one. That takes a lot of money. So how can we raise this money without patents? One way would be government funding, but there is plenty of public funding as well through foundations, etc. What is lacking is a well-developed infrastructure for a growing body of patentleft drugs, the same as software.
We need patentleft in drugs: http://magarshak.com/blog/?p=93 http://magarshak.com/blog/?p=93